StockWatch
·
Pharmaceuticals
Board Meeting22 May 2026, 02:58 pm

Shilpa Medicare Recommends ₹0.60 Dividend for FY26

AI Summary

Shilpa Medicare Ltd's board meeting on May 22, 2026, approved audited financial statements (standalone & consolidated) for FY26 with an unmodified audit opinion. A final dividend of ₹0.60 (60%) per equity share was recommended, pending member approval. M/s. V.J.Talati & Co. and M/s ANEJA ASSOCIATES were appointed as Cost Auditors and Internal Auditors, respectively, for FY 2026-27. The registered office shifting from Karnataka to Maharashtra is subject to member approval via postal ballot. Subsidiaries will invest 28% in Neo Green Power Project Private Limited. The registered offices of multiple wholly-owned subsidiaries will also shift to Maharashtra.

Key Highlights

  • Audited FY26 financial statements (standalone & consolidated) approved with unmodified opinion.
  • Final dividend of ₹0.60 per share recommended for FY26, pending shareholder approval.
  • V.J.Talati & Co. appointed as Cost Auditors for FY 2026-27.
  • ANEJA ASSOCIATES appointed as Internal Auditors for FY 2026-27.
  • Subsidiaries to make a 28% equity investment in Neo Green Power Project Private Limited.